Health & Medicine

A three‑year study of 6,500 Australian adolescents shows daily sugary‑drink intake increases the odds of meeting screening thresholds for depression and anxiety,…

Non-invasive blood tests are moving beyond niche use to become vital tools for tracking treatment response, detecting recurrence, and screening for cancer.

The 2026 AACR Cancer Progress Report highlights a rise in survival rates and the emergence of innovative drug classes like PROTACs and…

New clinical findings from MD Anderson highlight advanced immunotherapy and targeted treatments, offering renewed hope for lung and prostate cancer patients.

Researchers are moving beyond traditional toxic treatments by engineering the immune system to recognize and destroy cancer cells with greater precision.

Following the rapid recommendation of a new pancreatic cancer treatment, here is how the EMA assesses medical innovations for the European Union.

Viatris wins FDA approval for RYZUMVI to treat presbyopia, adding a new option for aging eyes while seeking a U.S. commercial partner.

As concierge practices surge in popularity, patients and providers must navigate complex Medicare rules regarding membership fees and covered services.

A $1.17 billion licensing agreement with Alector signals Genentech’s strategic pivot toward specialized neuro-autoimmune and rare disease biologics.

Explore the pharmacology of satralizumab, detailing its mechanism of action on IL-6 receptors and its expanding applications across autoimmune disorders.

The EMA has recommended approval for daraxonrasib, a daily pill that doubles survival rates for patients with metastatic pancreatic adenocarcinoma.

New research into lab-grown cells aims to overcome the scarcity and complexity of current CAR-T treatments, potentially expanding access for cancer patients.

A Nobel-winning discovery linked stomach bacteria to cancer, yet antibiotic resistance and screening gaps leave millions at risk—especially in low-income nations.

Thyroid eye disease, linked to Graves’ disease, occurs in 16 per 100,000 women annually, with smoking increasing risk nearly eightfold and severe…

Generalized myasthenia gravis is an autoimmune disorder where antibodies destroy acetylcholine receptors, leading to muscle weakness that worsens with activity and improves…

Zanidatamab’s unique mechanism and clinical data show promise for HER2-positive cancer treatment

A large-scale study found AI chatbot summaries aided physician preparation in 75% of cases and matched final diagnoses 90% of the time.

Researchers to investigate how power outages affect survival rates for patients relying on devices like ventilators or dialysis machines

The landmark trial published in NEJM found Dexcom G7 users achieved 0.9% greater A1C reduction versus routine care, with five more hours…

Despite rising prevention knowledge and fundraising success, scientists cite funding instability and complex tumor biology as key barriers to progress in cancer…

The FDA has broadened Anktiva’s use with BCG to include patients with BCG-unresponsive, high-grade papillary-only non-muscle-invasive bladder cancer, offering a bladder-preserving option…